Original Founders of Akkermansia Muciniphila Bring First Gut Health Product to U.S. Consumer Market
June 27, 2024 11:11 ET
|
The Akkermansia Company
The Akkermansia Company, founded by the first scientists to discover and decode Akkermansia muciniphila, announces its launch into the U.S. consumer market
Noom Introduces AI-Enabled Products to Enhance On-Demand Health Care and Interactive Coaching
June 27, 2024 08:04 ET
|
Noom Inc
Noom launches two state-of-the-art AI-powered features, AI food logging and Welli, Noom’s new AI personal health assistant.
Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
June 24, 2024 07:00 ET
|
Rani Therapeutics, LLC
~ New RT-114 obesity program combines ProGen’s FC Fusion protein conjugated GLP-1/GLP-2 dual agonist, PG-102, with the RaniPill® capsule designed to provide a differentiated oral delivery mechanism...
High Use of Ozempic and Other Diabetes Drugs for Weight Loss Driving Down Clothing Sizes In New York City, According to New Study
June 17, 2024 07:00 ET
|
Impact Analytics
Impact Analytics announced that size small has become the most popular size for women on Manhattan’s Upper East Side.
Noom Announces Strategic Expansion of Executive Team with Key Leadership Appointments
June 13, 2024 12:14 ET
|
Noom Inc
Noom, the leading digital healthcare company, announces the appointment of three distinguished executives to its leadership team.
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALT
May 27, 2024 10:31 ET
|
The Rosen Law Firm PA
NEW YORK, May 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between December 1, 2023 and...
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
May 23, 2024 09:05 ET
|
ResMed Inc.
New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
Amplify ETFs Launches The Amplify Weight Loss Drug & Treatment ETF (THNR)
May 21, 2024 07:00 ET
|
Amplify ETFs
Amplify ETFs announces the launch of the Amplify Weight Loss Drug & Treatment ETF (NYSE: THNR).
ALT INVESTOR NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALT
May 09, 2024 14:52 ET
|
The Rosen Law Firm PA
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of...
Noom Adds Muscle Defense™ to Its GLP-1 Companion Program to Help Prevent Muscle-Mass Loss While Taking GLP-1s
May 09, 2024 08:04 ET
|
Noom Inc
Noom launches Noom Move, an on-demand fitness offering, including Muscle Defense™, a curated movement program for those taking GLP-1 medications.